Breast cancer metastasis suppressor 1 (BRMS1) is destabilized by the Cul3-SPOP E3 ubiquitin ligase complex

Bogyou Kim1, Hye Jin Nam, Ki Eun Pyo

  • 1Department of Biological Sciences, Creative Research Initiative Center for Chromatin Dynamics, Seoul National University, Seoul 151-742, South Korea.

Insights

Breast cancer metastasis suppressor 1 (BRMS1) protein levels are regulated by the cullin 3-SPOP complex. This novel mechanism impacts breast cancer progression by controlling metastasis-associated genes.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Breast cancer metastasis suppressor 1 (BRMS1) inhibits cancer spread but its protein-level regulation remains unclear.
  • Understanding BRMS1 regulation is crucial for developing targeted breast cancer therapies.

Purpose of the Study:

  • To elucidate the post-translational regulatory mechanisms governing BRMS1 protein stability.
  • To identify novel binding partners and E3 ubiquitin ligase complexes involved in BRMS1 regulation.

Main Methods:

  • Co-immunoprecipitation assays to identify BRMS1 binding partners.
  • Ubiquitination assays to assess BRMS1 as a substrate.
  • RNA interference (RNAi) to knock down SPOP expression.
  • Quantitative real-time PCR to analyze target gene expression.

Main Results:

  • Cullin 3 (Cul3) was identified as a novel binding partner of BRMS1, with the SPOP adaptor protein mediating the interaction.
  • BRMS1 was found to be a substrate for ubiquitination by the Cul3-SPOP E3 ubiquitin ligase complex.
  • SPOP knockdown led to increased BRMS1 protein levels.
  • Reduced expression of BRMS1-repressed genes (e.g., Osteopontin (OPN) and Urokinase Plasminogen Activator (uPA)) was observed in breast cancer cells with SPOP knockdown.

Conclusions:

  • The Cul3-SPOP complex regulates BRMS1 protein stability through ubiquitination.
  • This novel regulatory pathway plays a significant role in breast cancer progression.
  • Targeting the Cul3-SPOP-BRMS1 axis may offer new therapeutic strategies for breast cancer metastasis.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Anaphase Promoting Complex00:50

Anaphase Promoting Complex

The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
The Spindle Assembly Checkpoint02:19

The Spindle Assembly Checkpoint

The spindle assembly checkpoint is a molecular surveillance mechanism ensuring the fidelity of chromosome segregation during anaphase. The checkpoint monitors the completion of all the prerequisite steps before chromosome segregation to determine whether the segregation process should proceed or be delayed.
Many proteins function together to control the spindle assembly checkpoint. Mutations affecting these proteins may allow cells to proceed into anaphase prematurely, resulting in the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...